TOPBP1 and cancer: As a result of the spontaneous mechanisms of cancer immunoediting, immunodominant MHC class I neoepitopes can sometimes be identified by analyzing a patient’s peripheral blood or TIL compartment25; however, subdominant neoepitopes may not be detectable in this manner, as we have observed with Topbp1.